Document is current
Any future updates will be listed below
-
Authors
Premer, Courtney https://orcid.org/0000-0001-6175-0049
Hare, Joshua M.
Yuan, Sarah Y.
Wilson, Jason W.
- License Information
-
More Information
Article History
Received: 25 March 2025
Accepted: 28 April 2025
First Online: 15 May 2025
Declarations
:
: n/a.
: All authors have given consent for publication in Stem Cell Research & Therapy.
: JMH is the Chief Scientific Officer, a compensated consultant and advisory board member for Longeveron, and holds equity in Longeveron. JMH is also the co-inventor of intellectual property licensed to Longeveron. The University of Miami also stands to gain royalties from the commercialization of the IP. JMH and CPB have a patent for monitoring efficacy of mesenchymal stem cell therapy. The other authors declare no competing interests.
